8:30am ET
Health and Healthcare
Why These 4 Biotech Stocks Could Be the Next Buyout Targets
A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in the biotech M&A excitement.
Companies
/Healthcare
Incyte Corp
$128.12
▼ $1.60 (−1.23%) today
Markets closed · 5:13pm ET
INCY Coverage
Page 7
8:20am ET
Health and Healthcare
The Next 3 Likely Biotech Buyout Candidates
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
9:15am ET
Investing
Insider Selling Remains Choppy as Stock Market Grinds Higher
In a trend that seems somewhat locked into place, insiders continue to sell stock, though as we have seen most of this year, nobody is rushing to the exits, at least for…
1:55pm ET
Health and Healthcare
Has Agenus Run Too Much?
Agenus, in conjunction with Incyte, announced a global license for the development and commercialization of Agenus's proprietary Retrocyte Display antibody discovery platform.
Chris Lange 2:10pm ET
Health and Healthcare
5 Critical Biotech Drug Dates and Events for December
At least five upcoming dates could be big days in December, for better or worse, for individual biotech stocks.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Aegerion, Avon, Atmel, LinkedIn, Ocwen, Visa and More
These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Friday, October 31, 2014.
10:15am ET
Health and Healthcare
Analyst Sees Incyte Worth 70% More
Incyte has serious upside potential, but the inherent risk within it may be too much for some investors to bear.
Chris Lange 8:15am ET
Investing
Top Analyst Upgrades and Downgrades: AEP, BHP, GE, Incyte, 3M, Tyco, Under Armour and More
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. for Wednesday, September 17, 2014.
9:10am ET
Health and Healthcare
SunTrust Robinson Humphrey Starts Coverage on 5 Top Biotech Stocks
SunTrust Robinson Humphrey opens up coverage of the biotech sector with four top biotech stocks to buy and one Neutral-rated stock.
8:40am ET
Health and Healthcare
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
8:40am ET
Health and Healthcare
Three Companies That Want to Cure Pancreatic Cancer
A new research report from Cowen cautions that progress on a cure for pancreatic cancer is slow, but steady. Drugs from three companies though have been favorably viewed by consultants.
8:30am ET
Health and Healthcare
Top Biotech Stocks for Cancer Cures From Cowen
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Buffalo Wild Wings, Coca-Cola, DSW, Intuitive Surgical and More
Here are the top analyst upgrades, downgrades and initiations seen from Wall Street on Tuesday, April 29, 2014. They include Buffalo Wild Wings, Coca-Cola, DSW and Intuitive Surgical.
8:50am ET
Health and Healthcare
UBS Top Stocks to Buy Working for Cancer Cures
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of…
9:05am ET
Health and Healthcare
J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside
In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off that may provide investors some incredible outsized gains over the rest of…